Last 12 months
Inside the activity.
3 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 2 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 1 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 05, 2019 Filed Mar 7, 2019 22:22 UTC |
Clark David JChief Medical Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 250,000 | $0.00 Strike: $8.05 | $0.00 |
DisclosureSEC source: 0000899243-19-006730 · doc4.xml · derivative · entry 2 Clark David J · CIK 0001662693 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 250,000 Underlying: Common Stock · 250,000 shares Expires 2029-03-04 F3 · derivative.exercise_date: The shares subject to this option shall vest in equal monthly installments over the next 48 months of continuous service to the Issuer after January 1, 2019. Read SEC document |
| March 05, 2019 Filed Mar 7, 2019 22:22 UTC |
Clark David JChief Medical Officer
|
GrantCommon Stock | 3,503 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-19-006730 · doc4.xml · nonDerivative · entry 1 Clark David J · CIK 0001662693 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,512 F1 · shares: Represents shares of common stock underlying a time-based restricted stock unit award (RSU). The RSU vests ratably in equal annual installments over a four-year period beginning on January 1, 2019, provided that the Reporting Person has provided continuous service to the Issuer through the applicable vesting date. F2 · balance_after: Includes 3,235 shares of common stock acquired under the Issuer's Employee Stock Purchase Plan (ESPP) in 2018. Read SEC document |
| March 05, 2019 Filed Mar 7, 2019 22:30 UTC |
McMullin DavidChief Commercial Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 45,212 | $0.00 Strike: $8.05 | $0.00 |
DisclosureSEC source: 0000899243-19-006734 · doc4.xml · derivative · entry 1 McMullin David · CIK 0001738662 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,212 Underlying: Common Stock · 45,212 shares Expires 2029-03-04 F1 · derivative.exercise_date: The shares subject to this option shall vest in equal monthly installments over the next 48 months of continuous service to the Issuer after January 1, 2019. Read SEC document |
| March 05, 2019 Filed Mar 7, 2019 22:20 UTC |
Brady Todd CDirector · President and CEO
|
GrantBonus Units · Derivative | 45,329 | $0.00 Strike: $8.05 | $0.00 |
DisclosureSEC source: 0000899243-19-006729 · doc4.xml · derivative · entry 3 Brady Todd C · CIK 0001579179 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,329 Underlying: Common Stock · 45,329 shares Expires not disclosed F4 · derivative.exercise_price: The bonus units vest in four (4) annual installments from the date of grant and entitle the Reporting Person to receive a cash payment, on the earlier of (i) four (4) years from the date of grant or (ii) a Change of Control of the Issuer (as defined in the grant documents), equal in value to the amount by which the then value of the Issuer's common stock exceeds the base value of $8.05. F4 · derivative.exercise_date: The bonus units vest in four (4) annual installments from the date of grant and entitle the Reporting Person to receive a cash payment, on the earlier of (i) four (4) years from the date of grant or (ii) a Change of Control of the Issuer (as defined in the grant documents), equal in value to the amount by which the then value of the Issuer's common stock exceeds the base value of $8.05. F4 · derivative.expiration_date: The bonus units vest in four (4) annual installments from the date of grant and entitle the Reporting Person to receive a cash payment, on the earlier of (i) four (4) years from the date of grant or (ii) a Change of Control of the Issuer (as defined in the grant documents), equal in value to the amount by which the then value of the Issuer's common stock exceeds the base value of $8.05. Read SEC document |
| March 05, 2019 Filed Mar 7, 2019 22:20 UTC |
Brady Todd CDirector · President and CEO
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 250,000 | $0.00 Strike: $8.05 | $0.00 |
DisclosureSEC source: 0000899243-19-006729 · doc4.xml · derivative · entry 2 Brady Todd C · CIK 0001579179 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 250,000 Underlying: Common Stock · 250,000 shares Expires 2029-03-04 F3 · derivative.exercise_date: The shares subject to this option shall vest in equal monthly installments over the next 48 months of continuous service to the Issuer after January 1, 2019. Read SEC document |
| March 05, 2019 Filed Mar 7, 2019 22:20 UTC |
Brady Todd CDirector · President and CEO
|
GrantCommon Stock | 250,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-19-006729 · doc4.xml · nonDerivative · entry 1 Brady Todd C · CIK 0001579179 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 556,054 F1 · shares: Represents shares of common stock underlying a time-based restricted stock unit award (RSU). The RSU vests ratably in equal annual installments over a four-year period beginning on January 1, 2019, provided that the Reporting Person has provided continuous service to the Issuer through the applicable vesting date. F2 · balance_after: Includes 3,571 shares of common stock acquired under the Issuer's Employee Stock Purchase Plan (ESPP) in 2018. Read SEC document |
| July 30, 2018 Filed Aug 1, 2018 20:46 UTC |
Reed JoshuaChief Financial Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 75,000 | $0.00 Strike: $6.80 | $0.00 |
DisclosureSEC source: 0000899243-18-020988 · doc4.xml · derivative · entry 1 Reed Joshua · CIK 0001746541 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Stock · 75,000 shares Expires 2028-07-29 F1 · derivative.exercise_date: 25% of the shares subject to this option shall vest after one year of continuous service to the Issuer. The balance of the shares subject to this option shall vest in equal monthly installments over the next 36 months of continuous service to the Issuer following the vesting commencement date. Read SEC document |
| June 07, 2018 Filed Jun 8, 2018 20:37 UTC |
DOUGLAS RICHARDDirector
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 632 | $0.00 Strike: $8.35 | $0.00 |
DisclosureSEC source: 0000899243-18-015770 · doc4.xml · derivative · entry 3 DOUGLAS RICHARD · CIK 0001021015 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 632 Underlying: Common Stock · 632 shares Expires 2028-06-06 F3 · derivative.exercise_date: Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Nominating/Corporate Governance Committee of the Board of Directors of the Issuer through the applicable vesting date. Read SEC document |
| June 07, 2018 Filed Jun 8, 2018 20:37 UTC |
DOUGLAS RICHARDDirector
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 5,416 | $0.00 Strike: $8.35 | $0.00 |
DisclosureSEC source: 0000899243-18-015770 · doc4.xml · derivative · entry 2 DOUGLAS RICHARD · CIK 0001021015 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,416 Underlying: Common Stock · 5,416 shares Expires 2028-06-06 F2 · derivative.exercise_date: Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as the Chairperson of the Board of Directors of the Issuer through the applicable vesting date. Read SEC document |
| June 07, 2018 Filed Jun 8, 2018 20:37 UTC |
DOUGLAS RICHARDDirector
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 15,526 | $0.00 Strike: $8.35 | $0.00 |
DisclosureSEC source: 0000899243-18-015770 · doc4.xml · derivative · entry 1 DOUGLAS RICHARD · CIK 0001021015 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,526 Underlying: Common Stock · 15,526 shares Expires 2028-06-06 F1 · derivative.exercise_date: Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Board of Directors of the Issuer through the applicable vesting date. Read SEC document |
| June 07, 2018 Filed Jun 8, 2018 16:35 UTC |
JOYCE MARTIN JOSEPHDirector
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 2,708 | $0.00 Strike: $8.35 | $0.00 |
DisclosureSEC source: 0000899243-18-015766 · doc4.xml · derivative · entry 3 JOYCE MARTIN JOSEPH · CIK 0001300858 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,708 Underlying: Common Stock · 2,708 shares Expires 2028-06-06 F3 · derivative.exercise_date: Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Audit Committee of the Board of Directors of the Issuer through the applicable vesting date. Read SEC document |
| June 07, 2018 Filed Jun 8, 2018 16:35 UTC |
JOYCE MARTIN JOSEPHDirector
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 632 | $0.00 Strike: $8.35 | $0.00 |
DisclosureSEC source: 0000899243-18-015766 · doc4.xml · derivative · entry 2 JOYCE MARTIN JOSEPH · CIK 0001300858 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 632 Underlying: Common Stock · 632 shares Expires 2028-06-06 F2 · derivative.exercise_date: Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Nominating/Corporate Governance Committee of the Board of Directors of the Issuer through the applicable vesting date. Read SEC document |
| June 07, 2018 Filed Jun 8, 2018 16:35 UTC |
JOYCE MARTIN JOSEPHDirector
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 15,526 | $0.00 Strike: $8.35 | $0.00 |
DisclosureSEC source: 0000899243-18-015766 · doc4.xml · derivative · entry 1 JOYCE MARTIN JOSEPH · CIK 0001300858 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,526 Underlying: Common Stock · 15,526 shares Expires 2028-06-06 F1 · derivative.exercise_date: Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Board of Directors of the Issuer through the applicable vesting date. Read SEC document |
| June 07, 2018 Filed Jun 8, 2018 20:35 UTC |
Phillips Gary M.Director
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 1,805 | $0.00 Strike: $8.35 | $0.00 |
DisclosureSEC source: 0000899243-18-015767 · doc4.xml · derivative · entry 2 Phillips Gary M. · CIK 0001197795 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,805 Underlying: Common Stock · 1,805 shares Expires 2028-06-06 F2 · derivative.exercise_date: Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Compensation Committee of the Board of Directors of the Issuer through the applicable vesting date. Read SEC document |
| June 07, 2018 Filed Jun 8, 2018 20:35 UTC |
Phillips Gary M.Director
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 15,526 | $0.00 Strike: $8.35 | $0.00 |
DisclosureSEC source: 0000899243-18-015767 · doc4.xml · derivative · entry 1 Phillips Gary M. · CIK 0001197795 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,526 Underlying: Common Stock · 15,526 shares Expires 2028-06-06 F1 · derivative.exercise_date: Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Board of Directors of the Issuer through the applicable vesting date. Read SEC document |
| June 07, 2018 Filed Jun 8, 2018 20:38 UTC |
Bronstein BenDirector
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 903 | $0.00 Strike: $8.35 | $0.00 |
DisclosureSEC source: 0000899243-18-015771 · doc4.xml · derivative · entry 3 Bronstein Ben · CIK 0001604458 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 903 Underlying: Common Stock · 903 shares Expires 2028-06-06 F3 · derivative.exercise_date: Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Compensation Committee of the Board of Directors of the Issuer through the applicable vesting date. Read SEC document |
| June 07, 2018 Filed Jun 8, 2018 20:38 UTC |
Bronstein BenDirector
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 1,354 | $0.00 Strike: $8.35 | $0.00 |
DisclosureSEC source: 0000899243-18-015771 · doc4.xml · derivative · entry 2 Bronstein Ben · CIK 0001604458 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,354 Underlying: Common Stock · 1,354 shares Expires 2028-06-06 F2 · derivative.exercise_date: Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Audit Committee of the Board of Directors of the Issuer through the applicable vesting date. Read SEC document |
| June 07, 2018 Filed Jun 8, 2018 20:38 UTC |
Bronstein BenDirector
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 15,526 | $0.00 Strike: $8.35 | $0.00 |
DisclosureSEC source: 0000899243-18-015771 · doc4.xml · derivative · entry 1 Bronstein Ben · CIK 0001604458 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,526 Underlying: Common Stock · 15,526 shares Expires 2028-06-06 F1 · derivative.exercise_date: Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Board of Directors of the Issuer through the applicable vesting date. Read SEC document |
| June 07, 2018 Filed Jun 8, 2018 20:36 UTC |
Walker NealDirector
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 903 | $0.00 Strike: $8.35 | $0.00 |
DisclosureSEC source: 0000899243-18-015769 · doc4.xml · derivative · entry 2 Walker Neal · CIK 0001604457 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 903 Underlying: Common Stock · 903 shares Expires 2028-06-06 F2 · derivative.exercise_date: Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Compensation Committee of the Board of Directors of the Issuer through the applicable vesting date. Read SEC document |
| June 07, 2018 Filed Jun 8, 2018 20:36 UTC |
Walker NealDirector
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 15,526 | $0.00 Strike: $8.35 | $0.00 |
DisclosureSEC source: 0000899243-18-015769 · doc4.xml · derivative · entry 1 Walker Neal · CIK 0001604457 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,526 Underlying: Common Stock · 15,526 shares Expires 2028-06-06 F1 · derivative.exercise_date: Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Board of Directors of the Issuer through the applicable vesting date. Read SEC document |
| June 07, 2018 Filed Jun 11, 2018 16:15 UTC |
TREU JESSE IDirector
|
GrantStock Option (right to buy) · Derivative | 1,444 | $0.00 Strike: $8.35 | $0.00 |
DisclosureSEC source: 0000904454-18-000424 · edgar.xml · derivative · entry 3 TREU JESSE I · CIK 0001013425 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,444 Underlying: Common Stock · 1,444 shares Expires 2028-06-06 F3 · derivative.exercise_date: The option is exercisable in full on the one-year anniversary of the grant date, subject to the Reporting Person's continuous service to the Issuer as the chairman of the Nominating and Corporate Governance Committee of the Board of Directors through such vesting date. Read SEC document |
| June 07, 2018 Filed Jun 11, 2018 16:15 UTC |
TREU JESSE IDirector
|
GrantStock Option (right to buy) · Derivative | 1,354 | $0.00 Strike: $8.35 | $0.00 |
DisclosureSEC source: 0000904454-18-000424 · edgar.xml · derivative · entry 2 TREU JESSE I · CIK 0001013425 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,354 Underlying: Common Stock · 1,354 shares Expires 2028-06-06 F2 · derivative.exercise_date: The option is exercisable in full on the one-year anniversary of the grant date, subject to the Reporting Person's continuous service to the Issuer as a member of the Audit Committee of the Board of Directors through such vesting date. Read SEC document |
| June 07, 2018 Filed Jun 11, 2018 16:15 UTC |
TREU JESSE IDirector
|
GrantStock Option (right to buy) · Derivative | 15,526 | $0.00 Strike: $8.35 | $0.00 |
DisclosureSEC source: 0000904454-18-000424 · edgar.xml · derivative · entry 1 TREU JESSE I · CIK 0001013425 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,526 Underlying: Common Stock · 15,526 shares Expires 2028-06-06 F1 · derivative.exercise_date: The option is exercisable in full on the one-year anniversary of the grant date, subject to the Reporting Person's continuous service to the Issuer as a member of the Board of Directors through such vesting date. Read SEC document |
| March 06, 2018 Filed Mar 8, 2018 21:40 UTC |
Brady Todd CDirector · President and CEO
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 217,293 | $0.00 Strike: $8.60 | $0.00 |
DisclosureSEC source: 0000899243-18-006819 · doc4.xml · derivative · entry 2 Brady Todd C · CIK 0001579179 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 217,293 Underlying: Common Stock · 217,293 shares Expires 2028-03-05 F3 · derivative.exercise_date: The shares subject to this option shall vest in equal monthly installments over the next 48 months of continuous service to the Issuer after January 1, 2018. Read SEC document |
| March 06, 2018 Filed Mar 8, 2018 21:40 UTC |
Brady Todd CDirector · President and CEO
|
GrantCommon Stock | 101,269 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-18-006819 · doc4.xml · nonDerivative · entry 1 Brady Todd C · CIK 0001579179 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 302,483 F1 · shares: Represents shares of common stock underlying a time-based restricted stock unit award (RSU). The RSU vests ratably in equal annual installments over a four-year period beginning on January 1, 2018, provided that the Reporting Person has provided continuous service to the Issuer through the applicable vesting date. F2 · shares: Includes 4,550 shares of common stock acquired under the Issuer's Employee Stock Purchase Plan (ESPP) in June 2017 and 575 shares of common stock acquired under the Issuer's ESPP in December 2017. Read SEC document |
| March 06, 2018 Filed Mar 8, 2018 21:40 UTC |
Clark David JChief Medical Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 108,633 | $0.00 Strike: $8.60 | $0.00 |
DisclosureSEC source: 0000899243-18-006818 · doc4.xml · derivative · entry 2 Clark David J · CIK 0001662693 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,633 Underlying: Common Stock · 108,633 shares Expires 2028-03-05 F3 · derivative.exercise_date: The shares subject to this option shall vest in equal monthly installments over the next 48 months of continuous service to the Issuer after January 1, 2018. Read SEC document |
| March 06, 2018 Filed Mar 8, 2018 21:38 UTC |
Tulipano Stephen JChief Financial Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 125,670 | $0.00 Strike: $8.60 | $0.00 |
DisclosureSEC source: 0000899243-18-006817 · doc4.xml · derivative · entry 3 Tulipano Stephen J · CIK 0001360548 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,670 Underlying: Common Stock · 125,670 shares Expires 2028-03-05 F5 · derivative.exercise_date: The shares subject to this option shall vest in equal monthly installments over the next 48 months of continuous service to the Issuer after January 1, 2018. Read SEC document |
| December 29, 2017 Filed Mar 8, 2018 21:40 UTC |
Clark David JChief Medical Officer
|
GrantCommon Stock | 4,774 | $4.00 | $19,072.13 |
DisclosureSEC source: 0000899243-18-006818 · doc4.xml · nonDerivative · entry 1 Clark David J · CIK 0001662693 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,774 F1 · date: Represents the voluntary reporting of 4,774 shares of common stock acquired under the Issuer's Employee Stock Purchase Plan (ESPP) in December 2017. F1 · shares: Represents the voluntary reporting of 4,774 shares of common stock acquired under the Issuer's Employee Stock Purchase Plan (ESPP) in December 2017. F2 · price: In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the Issuer's common stock on July 3, 2017. Read SEC document |
| December 29, 2017 Filed Mar 8, 2018 21:38 UTC |
Tulipano Stephen JChief Financial Officer
|
GrantCommon Stock | 3,153 | $4.00 | $12,596.24 |
DisclosureSEC source: 0000899243-18-006817 · doc4.xml · nonDerivative · entry 2 Tulipano Stephen J · CIK 0001360548 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,563 F3 · date: Represents the voluntary reporting of 3,153 shares of common stock acquired under the Issuer's ESPP in December 2017. F3 · shares: Represents the voluntary reporting of 3,153 shares of common stock acquired under the Issuer's ESPP in December 2017. F4 · price: In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the Issuer's common stock on July 3, 2017. Read SEC document |
| September 19, 2017 Filed Sep 21, 2017 12:45 UTC |
PERCEPTIVE ADVISORS LLC10% owner
EDELMAN JOSEPH10% owner
|
PurchaseCommon Stock | 200,000 | $7.25 | $1,450,000.00 |
DisclosureSEC source: 0001012975-17-000710 · edgar.xml · nonDerivative · entry 1 PERCEPTIVE ADVISORS LLC · CIK 0001224962 · 10% owner PERCEPTIVE LIFE SCIENCES MASTER FUND LTD · CIK 0001249675 · 10% owner EDELMAN JOSEPH · CIK 0001164426 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 3,085,458 F1 · ownership.nature: The securities are directly held by Perceptive Life Sciences Master Fund Ltd. (the "Master Fund"). Perceptive Advisors LLC (the "Advisor") serves as the investment manager of Master Fund. Joseph Edelman is the managing member of the Advisor. Each of Mr. Edelman and the Advisor disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of such securities, except to the extent of his/its indirect pecuniary interest therein, and this report shall not be deemed an admission that either Mr. Edelman or the Advisor is the beneficial owner of such securities for purposes of Section 16 or for any other purposes. Read SEC document |
| June 30, 2017 Filed Jul 5, 2017 21:56 UTC |
PERCEPTIVE ADVISORS LLC10% owner
EDELMAN JOSEPH10% owner
|
PurchaseCommon Stock | 296,007 | $4.60 | $1,361,632.20 |
DisclosureSEC source: 0001012975-17-000526 · edgar.xml · nonDerivative · entry 1 PERCEPTIVE ADVISORS LLC · CIK 0001224962 · 10% owner PERCEPTIVE LIFE SCIENCES MASTER FUND LTD · CIK 0001249675 · 10% owner EDELMAN JOSEPH · CIK 0001164426 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 2,885,458 F1 · ownership.nature: The securities are directly held by Perceptive Life Sciences Master Fund Ltd. (the "Master Fund"). Perceptive Advisors LLC (the "Advisor") serves as the investment manager of Master Fund. Joseph Edelman is the managing member of the Advisor. Each of Mr. Edelman and the Advisor disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of such securities, except to the extent of his/its indirect pecuniary interest therein, and this report shall not be deemed an admission that either Mr. Edelman or the Advisor is the beneficial owner of such securities for purposes of Section 16 or for any other purposes. Read SEC document |
| June 30, 2017 Filed Mar 8, 2018 21:38 UTC |
Tulipano Stephen JChief Financial Officer
|
GrantCommon Stock | 2,077 | $3.95 | $8,209.34 |
DisclosureSEC source: 0000899243-18-006817 · doc4.xml · nonDerivative · entry 1 Tulipano Stephen J · CIK 0001360548 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,410 F1 · date: Represents the voluntary reporting of 2,077 shares of common stock acquired under the Issuer's Employee Stock Purchase Plan (ESPP) in June 2017. F1 · shares: Represents the voluntary reporting of 2,077 shares of common stock acquired under the Issuer's Employee Stock Purchase Plan (ESPP) in June 2017. F2 · price: In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the Issuer's common stock on June 30, 2017. Read SEC document |
| June 08, 2017 Filed Jun 12, 2017 16:34 UTC |
TREU JESSE IDirector · 10% owner
|
GrantStock Option (right to buy) · Derivative | 2,370 | $0.00 Strike: $5.15 | $0.00 |
DisclosureSEC source: 0000904454-17-000440 · edgar.xml · derivative · entry 3 TREU JESSE I · CIK 0001013425 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,370 Underlying: Common Stock · 2,370 shares Expires 2027-06-07 F3 · derivative.exercise_date: The option is exercisable in full on the one-year anniversary of the grant date, subject to the Reporting Person's continuous service to the Issuer as the chairman of the Nominating and Corporate Governance Committee of the Board of Directors through such vesting date. Read SEC document |
| June 08, 2017 Filed Jun 12, 2017 16:34 UTC |
TREU JESSE IDirector · 10% owner
|
GrantStock Option (right to buy) · Derivative | 2,222 | $0.00 Strike: $5.15 | $0.00 |
DisclosureSEC source: 0000904454-17-000440 · edgar.xml · derivative · entry 2 TREU JESSE I · CIK 0001013425 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,222 Underlying: Common Stock · 2,222 shares Expires 2027-06-07 F2 · derivative.exercise_date: The option is exercisable in full on the one-year anniversary of the grant date, subject to the Reporting Person's continuous service to the Issuer as a member of the Audit Committee of the Board of Directors through such vesting date. Read SEC document |
| June 08, 2017 Filed Jun 12, 2017 16:34 UTC |
TREU JESSE IDirector · 10% owner
|
GrantStock Option (right to buy) · Derivative | 17,776 | $0.00 Strike: $5.15 | $0.00 |
DisclosureSEC source: 0000904454-17-000440 · edgar.xml · derivative · entry 1 TREU JESSE I · CIK 0001013425 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,776 Underlying: Common Stock · 17,776 shares Expires 2027-06-07 F1 · derivative.exercise_date: The option is exercisable in full on the one-year anniversary of the grant date, subject to the Reporting Person's continuous service to the Issuer as a member of the Board of Directors through such vesting date. Read SEC document |
| June 08, 2017 Filed Jun 12, 2017 21:05 UTC |
DOUGLAS RICHARDDirector
|
GrantStock Option (Right to Buy) · Derivative | 1,037 | $0.00 Strike: $5.15 | $0.00 |
DisclosureSEC source: 0000899243-17-016102 · doc4.xml · derivative · entry 3 DOUGLAS RICHARD · CIK 0001021015 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,037 Underlying: Common Stock · 1,037 shares Expires 2027-06-07 F3 · derivative.exercise_date: Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Nominating/Corporate Governance Committee of the Board of Directors of the Issuer through the applicable vesting date. Read SEC document |
| June 08, 2017 Filed Jun 12, 2017 21:05 UTC |
DOUGLAS RICHARDDirector
|
GrantStock Option (Right to Buy) · Derivative | 8,888 | $0.00 Strike: $5.15 | $0.00 |
DisclosureSEC source: 0000899243-17-016102 · doc4.xml · derivative · entry 2 DOUGLAS RICHARD · CIK 0001021015 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,888 Underlying: Common Stock · 8,888 shares Expires 2027-06-07 F2 · derivative.exercise_date: Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as the Chairperson of the Board of Directors of the Issuer through the applicable vesting date. Read SEC document |
| June 08, 2017 Filed Jun 12, 2017 21:05 UTC |
DOUGLAS RICHARDDirector
|
GrantStock Option (Right to Buy) · Derivative | 17,776 | $0.00 Strike: $5.15 | $0.00 |
DisclosureSEC source: 0000899243-17-016102 · doc4.xml · derivative · entry 1 DOUGLAS RICHARD · CIK 0001021015 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,776 Underlying: Common Stock · 17,776 shares Expires 2027-06-07 F1 · derivative.exercise_date: Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Board of Directors of the Issuer through the applicable vesting date. Read SEC document |
| June 08, 2017 Filed Jun 12, 2017 17:06 UTC |
JOYCE MARTIN JOSEPHDirector
|
GrantStock Option (Right to Buy) · Derivative | 1,037 | $0.00 Strike: $5.15 | $0.00 |
DisclosureSEC source: 0000899243-17-016104 · doc4.xml · derivative · entry 3 JOYCE MARTIN JOSEPH · CIK 0001300858 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,037 Underlying: Common Stock · 1,037 shares Expires 2027-06-07 F3 · derivative.exercise_date: Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Audit Committee of the Board of Directors of the Issuer through the applicable vesting date. Read SEC document |
| June 08, 2017 Filed Jun 12, 2017 17:06 UTC |
JOYCE MARTIN JOSEPHDirector
|
GrantStock Option (Right to Buy) · Derivative | 4,444 | $0.00 Strike: $5.15 | $0.00 |
DisclosureSEC source: 0000899243-17-016104 · doc4.xml · derivative · entry 2 JOYCE MARTIN JOSEPH · CIK 0001300858 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,444 Underlying: Common Stock · 4,444 shares Expires 2027-06-07 F2 · derivative.exercise_date: Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Nominating/Corporate Governance Committee of the Board of Directors of the Issuer through the applicable vesting date. Read SEC document |
| June 08, 2017 Filed Jun 12, 2017 17:06 UTC |
JOYCE MARTIN JOSEPHDirector
|
GrantStock Option (Right to Buy) · Derivative | 17,776 | $0.00 Strike: $5.15 | $0.00 |
DisclosureSEC source: 0000899243-17-016104 · doc4.xml · derivative · entry 1 JOYCE MARTIN JOSEPH · CIK 0001300858 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,776 Underlying: Common Stock · 17,776 shares Expires 2027-06-07 F1 · derivative.exercise_date: Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Board of Directors of the Issuer through the applicable vesting date. Read SEC document |
| June 08, 2017 Filed Jun 12, 2017 21:05 UTC |
Phillips Gary M.Director
|
GrantStock Option (Right to Buy) · Derivative | 2,963 | $0.00 Strike: $5.15 | $0.00 |
DisclosureSEC source: 0000899243-17-016101 · doc4.xml · derivative · entry 2 Phillips Gary M. · CIK 0001197795 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,963 Underlying: Common Stock · 2,963 shares Expires 2027-06-07 F2 · derivative.exercise_date: Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Compensation Committee of the Board of Directors of the Issuer through the applicable vesting date. Read SEC document |
| June 08, 2017 Filed Jun 12, 2017 21:05 UTC |
Phillips Gary M.Director
|
GrantStock Option (Right to Buy) · Derivative | 17,776 | $0.00 Strike: $5.15 | $0.00 |
DisclosureSEC source: 0000899243-17-016101 · doc4.xml · derivative · entry 1 Phillips Gary M. · CIK 0001197795 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,776 Underlying: Common Stock · 17,776 shares Expires 2027-06-07 F1 · derivative.exercise_date: Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Board of Directors of the Issuer through the applicable vesting date. Read SEC document |
| June 08, 2017 Filed Jun 12, 2017 21:07 UTC |
Bronstein BenDirector
|
GrantStock Option (Right to Buy) · Derivative | 1,481 | $0.00 Strike: $5.15 | $0.00 |
DisclosureSEC source: 0000899243-17-016105 · doc4.xml · derivative · entry 3 Bronstein Ben · CIK 0001604458 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,481 Underlying: Common Stock · 1,481 shares Expires 2027-06-07 F3 · derivative.exercise_date: Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Compensation Committee of the Board of Directors of the Issuer through the applicable vesting date. Read SEC document |
| June 08, 2017 Filed Jun 12, 2017 21:07 UTC |
Bronstein BenDirector
|
GrantStock Option (Right to Buy) · Derivative | 2,222 | $0.00 Strike: $5.15 | $0.00 |
DisclosureSEC source: 0000899243-17-016105 · doc4.xml · derivative · entry 2 Bronstein Ben · CIK 0001604458 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,222 Underlying: Common Stock · 2,222 shares Expires 2027-06-07 F2 · derivative.exercise_date: Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Audit Committee of the Board of Directors of the Issuer through the applicable vesting date. Read SEC document |
| June 08, 2017 Filed Jun 12, 2017 21:07 UTC |
Bronstein BenDirector
|
GrantStock Option (Right to Buy) · Derivative | 17,776 | $0.00 Strike: $5.15 | $0.00 |
DisclosureSEC source: 0000899243-17-016105 · doc4.xml · derivative · entry 1 Bronstein Ben · CIK 0001604458 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,776 Underlying: Common Stock · 17,776 shares Expires 2027-06-07 F1 · derivative.exercise_date: Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Board of Directors of the Issuer through the applicable vesting date. Read SEC document |
| June 08, 2017 Filed Jun 12, 2017 21:06 UTC |
Walker NealDirector
|
GrantStock Option (Right to Buy) · Derivative | 1,481 | $0.00 Strike: $5.15 | $0.00 |
DisclosureSEC source: 0000899243-17-016103 · doc4.xml · derivative · entry 2 Walker Neal · CIK 0001604457 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,481 Underlying: Common Stock · 1,481 shares Expires 2027-06-07 F2 · derivative.exercise_date: Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Compensation Committee of the Board of Directors of the Issuer through the applicable vesting date. Read SEC document |
| June 08, 2017 Filed Jun 12, 2017 21:06 UTC |
Walker NealDirector
|
GrantStock Option (Right to Buy) · Derivative | 17,776 | $0.00 Strike: $5.15 | $0.00 |
DisclosureSEC source: 0000899243-17-016103 · doc4.xml · derivative · entry 1 Walker Neal · CIK 0001604457 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,776 Underlying: Common Stock · 17,776 shares Expires 2027-06-07 F1 · derivative.exercise_date: Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Board of Directors of the Issuer through the applicable vesting date. Read SEC document |
| March 03, 2017 Filed Mar 7, 2017 22:45 UTC |
Clark David JChief Medical Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 155,656 | $0.00 Strike: $5.10 | $0.00 |
DisclosureSEC source: 0000899243-17-006713 · doc4.xml · derivative · entry 1 Clark David J · CIK 0001662693 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 155,656 Underlying: Common Stock · 155,656 shares Expires 2027-03-02 F1 · derivative.exercise_date: The shares subject to this option shall vest in equal monthly installments over the next 48 months of continuous service to the Issuer after January 1, 2017. Read SEC document |
| March 03, 2017 Filed Mar 7, 2017 22:45 UTC |
Brady Todd CDirector · President and CEO
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 250,000 | $0.00 Strike: $5.10 | $0.00 |
DisclosureSEC source: 0000899243-17-006712 · doc4.xml · derivative · entry 2 Brady Todd C · CIK 0001579179 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 250,000 Underlying: Common Stock · 250,000 shares Expires 2027-03-02 F2 · derivative.exercise_date: The shares subject to this option shall vest in equal monthly installments over the next 48 months of continuous service to the Issuer after January 1, 2017. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.